Pregnane X receptor-dependent and -independent effects of 2-acetylaminofluorene on cytochrome P450 3A23 expression and liver cell proliferation
- PMID: 12504080
- DOI: 10.1016/s0006-291x(02)02847-4
Pregnane X receptor-dependent and -independent effects of 2-acetylaminofluorene on cytochrome P450 3A23 expression and liver cell proliferation
Abstract
The arylamide 2-acetylaminofluorene (AAF) is a powerful carcinogen displaying a marked promoting activity, also known to regulate expression of liver detoxifying proteins. In this study we identified CYP3A23, a major inducible cytochrome P-450 (CYP) isoform, as an AAF target in hepatocytes. Indeed, exposure to AAF of primary rat hepatocytes resulted in a marked up-regulation of CYP3A23 expression at both mRNA and protein levels. Using CYP3A23 reporter gene constructs, we further demonstrated that AAF activated the CYP3A23 Direct Repeat 3 (DR3) promoter element interacting with the nuclear pregnane X receptor (PXR). Moreover, the PXR antagonist ecteinascidin-743 fully suppressed AAF-related CYP3A23 induction. Low doses of AAF inhibiting DNA synthesis in hepatocytes however failed to trigger PXR-related CYP3A23 induction and PXR-negative epithelial liver cells remained sensitive to the mito-inhibitory effects of AAF. Such data indicate that AAF up-regulates CYP3A23 through PXR activation but does not require PXR for exerting its carcinogenic promoting properties based on inhibition of cell growth.
Similar articles
-
Clofibrate and perfluorodecanoate both upregulate the expression of the pregnane X receptor but oppositely affect its ligand-dependent induction on cytochrome P450 3A23.Biochem Pharmacol. 2005 May 1;69(9):1363-71. doi: 10.1016/j.bcp.2005.02.011. Biochem Pharmacol. 2005. PMID: 15826607
-
Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23.Biochem Pharmacol. 2010 Oct 15;80(8):1274-83. doi: 10.1016/j.bcp.2010.06.043. Epub 2010 Jul 1. Biochem Pharmacol. 2010. PMID: 20599767 Free PMC article.
-
Simultaneous substitution of phenylalanine-305 and aspartate-318 of rat pregnane X receptor with the corresponding human residues abolishes the ability to transactivate the CYP3A23 promoter.J Pharmacol Exp Ther. 2005 Feb;312(2):571-82. doi: 10.1124/jpet.104.074971. Epub 2004 Sep 14. J Pharmacol Exp Ther. 2005. PMID: 15367577
-
Pharmaceutical use of mouse models humanized for the xenobiotic receptor.Drug Discov Today. 2002 May 1;7(9):509-15. doi: 10.1016/s1359-6446(02)02251-1. Drug Discov Today. 2002. PMID: 11983567 Review.
-
Phosphorylation and protein-protein interactions in PXR-mediated CYP3A repression.Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):861-73. doi: 10.1517/17425250903012360. Expert Opin Drug Metab Toxicol. 2009. PMID: 19505191 Free PMC article. Review.
Cited by
-
Marine Ligands of the Pregnane X Receptor (PXR): An Overview.Mar Drugs. 2019 Sep 28;17(10):554. doi: 10.3390/md17100554. Mar Drugs. 2019. PMID: 31569349 Free PMC article. Review.
-
Pregnane X receptor- and CYP3A4-humanized mouse models and their applications.Br J Pharmacol. 2011 Jun;163(3):461-8. doi: 10.1111/j.1476-5381.2010.01129.x. Br J Pharmacol. 2011. PMID: 21091656 Free PMC article. Review.
-
Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists.Pharm Res. 2009 Aug;26(8):1807-15. doi: 10.1007/s11095-009-9901-7. Epub 2009 May 5. Pharm Res. 2009. PMID: 19415465 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources